Undervalued Stocks Based On Cash Flows

Results

695

Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.

695 companies

CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv YieldIndustry
3180
JP¥1,438.00-1.6%-7.3%JP¥17.9bJP¥1,900.0019.822.3%1.3%Consumer Services
BWMX
US$18.25-1.0%97.7%US$679.7mUS$29.0010.126.3%6.7%Retail
LAZ
US$41.41-4.3%-22.2%US$4.1bUS$49.6315.124.4%4.8%Diversified Financials
QTWO
US$51.83-3.0%-42.6%US$3.2bUS$72.1843.927.6%n/aSoftware
MUR
zł37.90-1.3%-2.6%zł1.5bzł50.478.213.7%13.0%Real Estate Management and Development
CBHB
RM 0.69-1.4%150.9%RM 1.3bRM 0.7121.59.6%0.4%Capital Goods
KOSKI
€8.78-1.8%-0.7%€211.5m€8.5039.741.7%1.6%Materials
AXS
UK£0.73-0.3%24.4%UK£178.5mUK£1.1432.437.8%n/aMaterials
300492
CN¥23.09-11.7%-50.4%CN¥6.7bCN¥63.7126.442.6%1.9%Commercial Services
5838
JP¥5,804.007.0%-10.9%JP¥1.0tJP¥7,262.862.720.0%n/aBanks
ECEL
UK£1.09-1.8%-29.2%UK£106.6mUK£2.0511.131.7%5.9%Capital Goods
NWH
AU$6.90-1.7%125.5%AU$3.3bAU$6.9865.023.4%2.4%Capital Goods
INTR
US$5.822.3%-14.2%US$2.6bUS$9.381.321.9%1.9%Banks
300765
CN¥37.552.2%-26.8%CN¥53.9bCN¥49.1322.250.8%0.05%Pharmaceuticals & Biotech
2190
HK$19.28-2.3%-3.5%HK$6.4bHK$30.3122.825.4%1.3%Healthcare
GPC
US$125.62-2.4%1.0%US$17.3bUS$134.63287.740.5%3.4%Retail
BBT
US$30.19-0.2%13.0%US$2.5bUS$33.671.041.9%4.3%Banks
LHV1T
€3.35-0.4%-9.1%€1.1b€4.401.520.7%5.1%Banks
3923
JP¥1,022.00-1.1%-8.8%JP¥367.0bJP¥1,121.8827.211.7%0.8%Software
KVYO
US$16.91-0.5%-46.2%US$5.1bUS$28.903.982.4%n/aSoftware
ENT
UK£5.513.6%-41.9%UK£3.5bUK£9.470.789.4%3.6%Consumer Services
1436
JP¥1,387.00-3.9%87.6%JP¥17.6bn/a34.329.9%0.3%Utilities
TGS
NOK 130.804.0%59.2%NOK 25.7bNOK 152.382.050.7%4.6%Energy
VOS
€63.35-7.9%-28.3%€1.2b€83.4326.626.2%1.8%Capital Goods
Page 1 of 20